of glutamic acid, glutamine, methionine, tryptophan and histidine compared with healthy controls. 8 Similarly, other studies have confirmed low serum tryptophan concentrations in humans with IBD. 5, 9, 10 There is an anti-inflammatory effect of dietary intervention with tryptophan or tryptophan metabolites in experimental models of colitis, with supplementation ameliorating clinical signs, improving weight gain and histological scores and decreasing gut permeability and expression of proinflammatory cytokines. 11, 12 Similarly, supplementation with glutamine, arginine, N-acetylcysteine, and glycine in animal models of IBD has beneficial effects such as reduced intestinal permeability and decreased production of proinflammatory cytokines. [13] [14] [15] [16] Dogs with protein-losing enteropathy (PLE) have increased loss of protein from the intestinal tract resulting in hypoproteinemia. These animals likely also have a higher requirement for dietary protein because of increased demand from ongoing inflammation. Therefore, dogs with PLE might be at increased risk of developing an essential amino acid deficiency, especially as they might not be able to replenish their increased losses or meet their increased demands because of hyporexia or anorexia caused by their disease. Therefore, given the important functions of certain amino acids in the GI tract, a deficiency might contribute to or exacerbate disease in these dogs.
The aims of our study were to determine, (1) whether serum amino acid concentrations in dogs with PLE differ from healthy dogs and (2) to correlate any significant changes with age at diagnosis, clinical signs, and canine chronic enteropathy activity index (CCEAI) 17 ; laboratory variables, and survival.
| M A TE RI A L S A ND M E TH ODS

| Retrospective study criteria for case selection
The medical records at the Bristol Veterinary School were searched for dogs presented between January 2012 and October 2017 with a diagnosis of PLE. All medical records then were reviewed by one of the authors (A. Kathrani) 
| Selection of control dogs
Serum samples from 12 dogs from which food was withheld for [10] [11] [12] hours, which were considered to be apparently healthy based on history, physical examination, complete blood count, and biochemistry panel were selected as controls. Dogs that were evaluated as apparently healthy were blood donors (4 dogs) or undergoing routine dental procedures (8 dogs). Serum was stored in 2208C for a similar time period as the PLE dogs and was retrieved from the archive at the Bristol Veterinary School and sent to the Amino Acid Laboratory at the University of California, Davis on dry ice for serum amino acid analysis.
| Serum amino acid analysis
-hydroxyproline, and L-proline were analyzed with an automated high-performance liquid chromatography amino acid analyzer (Biochrom 30, Biochrom Ltd, Holliston, Massachusetts), using a method described elsewhere. 18 The R 2 of calculated standard curves of major amino acids were-> 0.9995. Internal standard recovery range of each sample was within 97%-100% and relative variances of major amino acids between duplicates were <2%. The detection limit of major amino acids was 0.1 nmol/mL with 50 lL load and recovery rates of spiking standards (addition of 200 nmol/mL) were 97%-102%.
| Ethical considerations
Stored residual blood was used in our study and the University of Bristol granted ethical approval for the study (VIN/17/026).
| Data analysis and statistics
Analyses were performed using a computer software package (IBM SPSS Statistics Version 23). The Mann-Whitney U test and Fisher's exact test were used to determine if there were any significant differences in age and sex/neuter status between the PLE and apparently healthy dogs, respectively.
The Shapiro-Wilk test was used to determine if the concentrations of each of the 30 amino acids were normally distributed. For those amino acids that were normally distributed, a t-test was used to determine if there were any significant differences between concentrations in the dogs with PLE versus the apparently healthy dogs. For amino acids that were not normally distributed, a Mann-Whitney U test was used to determine if there were any significant differences between concentrations in the dogs with PLE versus the apparently healthy dogs. A Bonferroni correction was applied, so that significance was defined as P < .0017.
For those amino acids that were significantly different between dogs with PLE and those that were apparently healthy, a simple logistic regression analysis was used to determine if there were any significant associations between the amino acid concentrations in the PLE dogs and age at diagnosis; chronicity of clinical signs; appetite, percentage body weight loss; body condition score (BCS); serum albumin, globulin, cholesterol, cobalamin, and folate concentrations; CCEAI; whether the diet consumed at diagnosis met the WSAVA Global Nutrition Committee Guidelines, survival versus death because of PLE, days to death or euthanasia because of PLE and serum sample storage time in 2208C.
Variables associated with the amino acid concentrations in the PLE dogs with P < .2 in simple linear regression were entered into multivariable analyses. In the multivariable regression models, analyses were performed in a backward stepwise manner. All variables with P < .2
were initially included, and the variable with the highest P-value was removed until all remaining variables had a P < .05.
| R E SU LTS
| Dogs
Thirty dogs with PLE were included in the study: 1 intact male, 14 neu- There were no significant differences in age and sex/neuter status between the PLE and apparently healthy dogs (P > .15).
| History
Duration of clinical signs for all PLE dogs ranged between 1 day and 570 days (median, 60 days). Twenty dogs (67%) were reported to have lost weight (median 9.35% body weight loss, range 4%-28%), 2 dogs (7%) were reported to be weight stable, and weight changes were unreported for 8 dogs (27%). Four dogs (13%) were anorexic, 10 dogs (33%) were hyporexic, 11 dogs (37%) had an unchanged appetite, 3
(10%) were reported to be polyphagic, and appetite was unreported in 
| Histologic diagnosis
Twenty-eight of the 30 PLE dogs (93%) had histopathology of intestinal biopsies performed. All biopsy specimens were collected using endos- 
| Outcome
Thirteen of the 30 PLE dogs (43%) died or were euthanized because of the disease; 2 died (7%) and 11 (37%) were euthanized. Two (7%) were euthanized before discharge from the hospital and 11 (37%) were euthanized or died after (median days of survival after discharge from hospital, 18; range 6-180 days). Four of the 30 PLE dogs (13%) were euthanized because of diseases unrelated to their PLE; 2 of these dogs were euthanized 4 years and 1 dog 1.8 years after initial discharge from the hospital. Thirteen of the PLE dogs (43%) were still alive at the time of our study (median, 0.6 years; range 0.1-4.0 years).
| Serum amino acid concentrations
Serum tryptophan concentrations were significantly lower in dogs with PLE compared with apparently healthy dogs (PLE: median, 22 nmol/ mL; range, 1-80 nmol/mL; apparently healthy: median, 77.5 nmol/mL; range, 42-135 nmol/mL, P < .001, Table 1 , and Figure 1 ).
There were no significant differences in the remaining 29 serum amino acids between dogs with PLE and apparently healthy (Table 1) .
| Correlation of serum tryptophan concentrations with various variables in the PLE dogs
In the simple linear regression analyses, age at diagnosis; appetite; per- 
| D ISC USSION
In our study, serum tryptophan concentrations were significantly decreased in 30 dogs with PLE compared with 12 apparently healthy dogs. Tryptophan is a dietary essential amino acid in dogs; it is important for protein synthesis as well as serving as a precursor for additional bioactive compounds such as kynurenine, serotonin, melatonin, and picolinic acid. 19 The kynurenine pathway comprises at least 90% of tryptophan catabolism. 19, 20 The enzyme indoleamine 2,3, dioxygenase 1 (IDO-1) is the initial rate-limiting step in the pathway for the oxidation of tryptophan to kynurenine. 19 Increased IDO-1 expression in human IBD is associated with lower serum tryptophan concentrations and a higher serum kynurenine tryptophan ratio because of increased tryptophan catabolism. 9 Therefore, decreased serum tryptophan concentrations in dogs with PLE in our study might be because of a similar mechanism of increased IDO-1 expression in the intestinal tract resulting in increased catabolism of tryptophan. However, further studies measuring concurrent serum kynurenine in dogs with PLE and expression of IDO-1 in intestinal biopsies would be needed to confirm this mechanism as the cause of decreased serum tryptophan concentrations in dogs with PLE.
Studies have also shown an association between serum tryptophan concentrations and disease activity in humans with IBD. 5, 9 Although our study did not document an association between CCEAI or outcome and serum tryptophan concentrations in PLE dogs, there was a significant correlation with serum albumin concentrations. Therefore, as serum albumin concentration is an indicator of the severity of loss from the GI tract, our study showed that serum tryptophan concentrations are worse in those dogs with PLE with increased loss and therefore could be an indicator of severity of inflammation at the level of the intestinal tract because of increased IDO-1 expression. However, additional studies would be needed to confirm this hypothesis. Although tryptophan is reversibly bound to albumin in serum resulting in bound and free fractions, our study measured only free tryptophan in serum and therefore is unlikely to have been directly affected by the serum albumin concentrations. In addition, serum concentrations of free tryptophan in humans with chronic renal failure were shown to be uninfluenced by serum protein concentrations and the free fraction was normal in those patients with hypoalbuminemia. 21 Therefore, our study demonstrated that in dogs with PLE, as serum albumin decreases, serum tryptophan concentrations decrease. Decreasing albumin concentrations are typically associated with more severe disease in dogs with PLE. Therefore, serum tryptophan concentration might also be an indicator of disease severity An additional possibility for decreased serum tryptophan concentrations in dogs with PLE in our study could have been because of the diet the dogs were consuming. Unfortunately, the correlation between dietary tryptophan intake and serum concentrations was not able to be determined in our study, however, further studies assessing the serum kynurenine tryptophan ratio might help to avert any potential bias generated by differences in individual dietary intake. 22, 23 Another important limitation of our study includes the absence of published reference ranges for serum amino acids in dogs. Serum was chosen to measure 24 further studies should focus on a breed-matched control group to remove any possible confounding effects from breed variation.
Although the role of prolonged freezing on serum amino acids in dogs is also unknown, the dogs in the apparently healthy group had serum stored in 2208C over a similar time period as dogs in the PLE group and none of the remaining 29 amino acids were shown to be significantly different between the 2 groups. One study documented that storage of human serum at 2208C for up to 26 weeks did not significantly affect serum tryptophan concentrations. 25 A study reported a mean and standard deviation (SD) of serum tryptophan concentrations using high performance liquid chromatography from samples that had been frozen for a shorter duration (5 months) in 9 clinically healthy bitches of 5 different breeds as 68.44 and 21.77 nmol/mL, which was not dissimilar to the results obtained in our apparently healthy group, using frozen serum stored for a longer duration. 26 However, further studies are needed to determine the effect of prolonged storage in 
